Fudosteine Tablets

This product is a mucolytic agent, which can inhibit the excessive formation of goblet cells that secrete mucous sputum in the trachea, and inhibit the production of high-viscosity fucoxomucin, thereby reducing the viscosity of sputum and making it easier to cough up. This product can also increase serous tracheal secretion and inhibit tracheal inflammation.

(-)-3-[(3-Hydroxypropyl)thio]-L-alanine

This product is a white film-coated tablet, which appears white after removing the film coating.

Used for expectorant treatment of respiratory diseases such as bronchial asthma, chronic asthmatic bronchitis, bronchiectasis, pulmonary tuberculosis, pneumoconiosis, chronic obstructive pulmonary emphysema, atypical mycobacterial disease, pneumonia, diffuse bronchitis, etc.

Oral administration. Usually adults take 0.4g each time, three times a day, after meals. The dosage can be adjusted appropriately according to age and symptoms.

1. Digestive system: loss of appetite, nausea, vomiting, abdominal pain, stomach pain, stomach discomfort, burning sensation in the stomach, abdominal distension, dry mouth, diarrhea, constipation, etc. (0.1% to 5%). 2. Sensory organs: tinnitus, abnormal taste (0.1% to 5%). 3. Mental and nervous system: headache, numbness, dizziness (0.1% to 5%).

It is contraindicated for those who are allergic to this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

seal

0.2g

36 months

Disha Pharmaceutical Group Co., Ltd.

• Founded in:

  1997-04-30

• Address:

  No. 1-4, Qingdao South Road, Weihai Economic and Technological Zone

• Tax NO.:

  913710007062493501

• Registered Funds:

  599.7706277 yuan

• Website:

  Log in to view

• Email:

  Log in to view